Epistem's specialist research services provide valuable support to drug discovery and development pipelines. Epistem’s experienced and skilled technical team are dedicated to working with you to provide custom protocols and a personalised service of the highest standard. We have worked with over 200 pharmaceutical and biotechnology companies providing preclinical and clinical services.
Preclinical services include both in vitro and in vivo, with a focus on oncology and inflammatory diseases and extensive experience with the gastrointestinal disease area, including GI toxicities. GCLP accredited laboratories provide histology, IHC and image analysis support along with gene expression and DNA genotyping services.
Epistem's proprietary RNA-amp technology facilitates the analysis of gene expression from very low amounts of starting material such as circulating tumour cells and liquid biopsies.
We operate on both a contractual fee for service model as well as in collaborative partnerships, particularly for model development and in biomarker and target discovery programs. Our high level of expertise and customer focus has led to an enviable track record and impressive repeat business ratio.